BioMed21 Collaboration

We work to advance and promote human-centric, nonanimal approaches in science research.

[BioMed21 Collaboration @BioMed_21]

Join our webinar on Rare Disease Research & Drug Development with NAMs in the EU.

We'll explore how human-relevant NAMs, incl. advanced 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 systems & 𝘪𝘯 𝘴𝘪𝘭𝘪𝘤𝘰 models, can help transform rare disease modelling & accelerate drug dev.

🔗https://t.co/3aEDbBId1l

[BioMed21 Collaboration @BioMed_21]

New funding opportunity from the US @NIH supporting centers advancing non-animal methods (NAMs) and human-based research technologies. Facilities focused primarily on animal research are not among the priorities of this announcement.

💡Learn more & apply: https://t.co/tZJH8WZx5a

[BioMed21 Collaboration @BioMed_21]

We were pleased to attend Ombion Centre for Animal-free Biomedical Translation’s scientific conference, where they shared news of our "Human by Design" course. Thanks Valentin Salamone & Ombion for introducing the course & congrats on a successful event! https://t.co/pJPh1iE80j

[BioMed21 Collaboration @BioMed_21]

📡 BIG NEWS! 📡 We’re excited to announce that, together with @humaneworldorg & @UniUtrecht, we're developing a course that will train the next generation of researchers in animal-free science!

Learn more & register your interest in our latest blog post: https://t.co/pJPh1iE80j

[BioMed21 Collaboration @BioMed_21]

📢 Something exciting is on the horizon for those who want to move beyond animal research.

We’re joining forces with international partners to launch a bold project to accelerate the growing shift toward more human-relevant science.

More details coming tomorrow!

[BioMed21 Collaboration @BioMed_21]

On #WorldCancerDay, it’s time to rethink how we study this disease. Over 90% of cancer drugs that pass animals tests fail in human trials—a sign we need a change. The future of cancer research is human-centric, data-driven & interdisciplinary—we’re working to make that a reality.

[BioMed21 Collaboration @BioMed_21]

🚀 ICYMI: The @BioMed_21 Collaboration has launched a bold new moonshot policy paper calling for a transformative shift in biomedical research—toward human-specific, non-animal methods.

Read the full paper here: https://t.co/rNQ3SM8BxN

[Humane World End Animal Testing @humaneworldeat]

ICYMI: Our new “moonshot” policy paper with @BioMed_21 calls for a bold shift from outdated animal tests to human-relevant, animal-free methods that better predict how diseases & treatments affect people.

Read more in our latest @POLITICOEurope article: https://t.co/wtjJKglheR

[BioMed21 Collaboration @BioMed_21]

Our work to progress human-centric, non-animal methods has never been more important, and we look forward to continuing our work in 2026 and beyond to make this global vision a reality. 🎉

[BioMed21 Collaboration @BioMed_21]

Happy holidays to our partners, members and supporters. Thank you for your continued commitment to advancing human-centric nonanimal science. We look forward to building on our shared progress in the new year as we work together to better protect people, animals and our planet.

[BioMed21 Collaboration @BioMed_21]

We are proud to announce our new moonshot policy paper, calling for a transformative "moonshot" in biomedical research: accelerating the shift to human-relevant, non-animal technologies to tackle major public health challenges. 🚀🧪🧬

🔗https://t.co/rNQ3SM83If

[BioMed21 Collaboration @BioMed_21]

📢 BREAKING: @EU_Commission’s newly introduced Biotech Act formally recognizes non-animal methods (NAMs) as “critical research & technology infrastructure”, showing that our, & @humaneworldorg's recommendations were taken into account! This is great news for animal-free science!

[BioMed21 Collaboration @BioMed_21]

Our roundtable brought together global partners & experts to share progress & next steps to advance human-centered, non-animal methods.

Thank you to all participants for the inspiring discussions & shared commitment to transform biomedical research for the 21st century. 🧪🚀

[BioMed21 Collaboration @BioMed_21]

We celebrate the @US_FDA's latest draft guidance that will allow for reduction—& in some cases elimination—of certain non-human primate toxicity tests for drug development.

This update reflects growing trust in non-animal, human-relevant methods.​

🔗 https://t.co/SWxKPT17TW

[BioMed21 Collaboration @BioMed_21]

We welcome the U.S. @CDCgov's reported decision to end its in-house primate research program—this would be a landmark step supporting the application of human-centric biomedical innovation to enhance public health. https://t.co/LQyB1fDi6y

[Animal-Free Safety Assessment (AFSA) Collaboration @AFSAcollab]

We welcome the publication of UK Government's plan for replacing animal in science. Animal-free methods provide better safety for humans, environment & prevent animal suffering. We look forward to contributing our experience & expertise to ensure implementation of this strategy.

[BioMed21 Collaboration @BioMed_21]

We're encouraged to see @NIH embrace human-based non-animal methods in biomedical research, with NIH's Dr. Nicole Kleinstreuer at the forefront.

Learn more about Kleinstreuer, winner of #BioMed21 member, @humaneworldorg's, Humane Science Innovator Award! https://t.co/hBTpvN9eU1

[BioMed21 Collaboration @BioMed_21]

🎬 Here’s a sneak peek of our inaugural science policy workshop video! This event brought together leading experts in Brussels, Belgium to explore how human-centric, non-animal research strategies can transform biomedical research & public health.

Stay tuned for the full video!

[BioMed21 Collaboration @BioMed_21]

The increasingly-recognized failure of animal models to reliably predict human biology is driving a shift in medical research toward human-based approaches.

This @CBC article on “organ chip” cancer research exemplifies this transition in Canada: https://t.co/TcXIwAdSbJ

[BioMed21 Collaboration @BioMed_21]

Our findings highlight the systemic pressure to use animal methods & how they are viewed as the default gold standard, despite evidence that human-relevant tech can better mimic & predict human responses.

Read full report: https://t.co/3ZDsj6Ezai

Part of the @TheCOLAAB project.

[BioMed21 Collaboration @BioMed_21]

Our survey on animal methods bias, conducted w/ @humaneworldind, @IndiaBioscience, @cphms_aic & @PCRM, revealed concerning trends:

🚨 56% of respondents were asked to add animal tests to studies w/out them.

🚨 30% of respondents included animal data just to satisfy reviewers.